Project factsheets

The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.

IMI1/IMI2/IHI

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 12 projects/programmes

ADAPT-SMART

Accelerated development of appropriate patient therapies: a sustainable, multi-stakeholder approach from research to treatment-outcomes

GETREAL

Incorporating real-life clinical data into drug development

Closed IMI1 Clinical trial design Real-world data, evidence Regulatory and HTA processes

GetReal Initiative

The GetReal Initiative

Closed IMI2 Clinical trial design Real-world data, evidence Regulatory and HTA processes

PARADIGM

Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes

Closed IMI2 Clinical trial design Patient involvement in R&D Regulatory and HTA processes

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle

Closed IMI2 Clinical trial design Patient involvement in R&D Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

PREMIER

Prioritisation and risk evaluation of medicines in the environment

Ongoing IMI2 Real-world data, evidence Regulatory and HTA processes Environmental aspects

RESCEU

Respiratory syncytial virus consortium in Europe

Ongoing IMI2 Respiratory diseases Infectious diseases Biobanks Regulatory and HTA processes

SISAQOL-IMI

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Ongoing IMI2 Cancer Clinical trial design Patient involvement in R&D Regulatory and HTA processes

Trials@Home

Center of excellence – remote decentralised clinical trials

Ongoing IMI2 Clinical trial design Digital health Real-world data, evidence Regulatory and HTA processes

VAC2VAC

Vaccine lot to vaccine lot comparison by consistency testing

Ongoing IMI2 Infectious diseases Vaccines 3Rs - animal use in research Regulatory and HTA processes

WEB-RADR

Recognising Adverse Drug Reactions

Closed IMI1 Tools for predicting/monitoring efficacy Digital health Regulatory and HTA processes

WEB-RADR 2

Closed IMI2 Tools for predicting/monitoring safety Big data and knowledge management Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment